🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 8 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/09/1997 46,50 46,50 44,25 45,00 +0,00% 4,84% 17.617
25/09/1997 41,25 45,00 41,25 45,00 +9,09% 9,09% 17.683
24/09/1997 42,00 42,00 41,25 41,25 +0,00% 1,79% 4.117
23/09/1997 42,00 42,00 41,25 41,25 -0,90% 1,79% 5.300
22/09/1997 42,38 42,38 41,63 41,63 +0,00% 1,77% 5.850
19/09/1997 41,25 42,38 41,25 41,63 +0,91% 2,73% 3.850
18/09/1997 42,00 42,00 41,25 41,25 -0,90% 1,79% 15.567
17/09/1997 40,13 42,00 40,13 41,63 +3,26% 4,67% 4.817
16/09/1997 41,25 41,25 39,75 40,31 -2,27% 3,64% 11.833
15/09/1997 40,88 41,25 39,75 41,25 +3,77% 3,67% 1.250
12/09/1997 40,13 40,88 39,75 39,75 -1,40% 2,80% 7.850
11/09/1997 40,13 41,25 40,13 40,31 -2,27% 2,80% 5.100
10/09/1997 41,25 41,25 40,13 41,25 +0,00% 2,73% 5.800
09/09/1997 41,25 41,25 40,50 41,25 +0,92% 1,82% 4.800
08/09/1997 40,50 41,25 40,50 40,88 +1,40% 1,85% 5.217
05/09/1997 41,25 41,25 40,13 40,31 -2,27% 2,73% 3.517
04/09/1997 41,25 41,63 39,75 41,25 +0,92% 4,55% 13.800
03/09/1997 39,00 41,25 38,25 40,88 +2,83% 7,69% 18.633
02/09/1997 40,50 40,88 39,38 39,75 +0,95% 3,70% 1.300
29/08/1997 39,75 40,50 39,38 39,38 -0,94% 2,83% 3.683
28/08/1997 40,13 41,63 39,75 39,75 -0,93% 4,67% 3.633
27/08/1997 42,00 42,00 40,13 40,13 -4,46% 4,46% 7.267
26/08/1997 42,00 42,00 40,88 42,00 +0,90% 2,68% 6.367
25/08/1997 41,63 42,38 40,88 41,63 +0,91% 3,60% 7.300
22/08/1997 42,00 42,00 41,25 41,25 +0,00% 1,79% 11.033
21/08/1997 40,13 42,00 39,75 41,25 +2,80% 5,61% 5.700
20/08/1997 40,50 40,88 40,13 40,13 -0,93% 1,85% 4.367
19/08/1997 40,69 41,25 40,50 40,50 +0,93% 1,84% 4.133
18/08/1997 43,50 43,50 39,75 40,13 -6,14% 8,62% 4.600
15/08/1997 45,00 45,00 42,75 42,75 -3,39% 5,00% 2.450